Neuroendocrine breast carcinoma metastatic to renal cell carcinoma and ipsilateral adrenal gland. 204 (11 To our knowledge this is the first case of neuroendocrine breast carcinoma with metastasis to renal cell carcinoma and ipsilateral adrenal gland.
Introduction
Breast cancer is the most common malignant tumor and the main cause of tumorrelated death in women. Its occurrence with other primary malignances, especially renal cell carcinoma, is not a rare event. However, tumor metastatic to another neoplasm is rarely seen.
There are four cases of breast cancer metastasis to renal cell carcinoma described in the literature [7, 15, 17, 18] . We report the first case of breast carcinoma showing neuroendocrine differentiation with metastasis to the renal cell carcinoma and ipsilateral adrenal gland.
Clinical history
A 60-year-old woman presented with painless macrohematuria persisting for several months. Clinical examination including ultrasound, intravenous pyelography and CT scan showed a well circumscribed tumor on the upper pole of the left kidney. The tumor of the left breast was also found. Nephrectomy with ureterectomy was performed. During the same operation, the left adrenal gland and spleen were removed. The patient underwent mastectomy with axillary lymph node dissection two months later.
The patient received postoperative radiation therapy followed by hormonal treatment.
The patient is 18 months after second surgery well and without recurrence.
Material and methods
Specimens were fixed in 10% buffered formalin, embedded in paraffin, cut at 5 µm thickness, and routinely stained with hematoxylin and eosin. Immunohistochemical staining was performed following Microwave Streptavidin ImmunoPeroxidase (MSIP) protocol on DAKO TechMate Horizon automated immunostainer using following primary antibodies CK7, CK19, CK20, AE1-AE3, EMA, synaptophysin, S-100, chromogranin A, vimentin, 
Results
Grossly, the kidney showed a yellow, well circumscribed tumor, 11 cm in largest diameter, with elevated capsule but limited to the kidney (Fig. 1A) . Histopathologic diagnosis revealed typical renal cell carcinoma (RCC) with foci of solid sheets of hyperchromatic epitheloid cells with high mitotic activity and apoptosis ( Fig. 1B and C (Table 1) . Diagnosis of invasive ductal carcinoma with neuroendocrine differentiation was made and classified as poorly differentiated neuroendocrine carcinoma according to the WHO classification [16] .
From axillary fat 2 conglomerates of lymphatic tissue measuring 3 and 4 cm in the largest diameter and 9 lymph nodes were isolated and tumorous tissue identical to that described in the breast was found in all nodes. The tumor of the breast was staged as T4N2M1 and G3.
On the basis of similar histology and imunohistochemical profile of neuroendocrine cells in RCC and neuroendocrine cells in the breast carcinoma we concluded that breast carcinoma metastasized to RCC; therefore, the initial diagnosis was changed in accordance to new findings.
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Discussion
The occurrence of multiple primary malignances is a rare but well-known phenomenon. It has been reported in 2.3% of clinical and 8.1% of autopsy series [10] . RCC is the most common tumor found to coexist with other malignancies [1, 10, 12, 13, 14] . In different studies the incidence of second primary malignancy associated with RCC is reported to be 12%-27.4% [1, 10, 11, 14] . About 19% of these tumors appeared synchronously [1] . Other primary malignant tumors most often associated with RCC are bladder, prostate, colorectal and lung cancer [1, 10, 12, 20] . Breast cancer is also one of the tumors known to coexist with RCC [1, 11] .
Tumor to tumor metastasis is a very rare event. Campbell et al. [3] established criteria for metastatic carcinoma to a second primary carcinoma: evidence for the existence of more than one primary tumor; the recipient tumor shown to be a true neoplasm; and evidence that the second malignant neoplasm is a true metastasis with established growth or invasion in the host tumor and not due to contiguous growth or embolism of tumor cells. By these criteria less than 60 cases of tumor to tumor metastasis can be found in PubMed.
The first case of tumor to tumor metastasis was described by Berent in 1902 [2] ; it was a squamous epithelial cancer to an RCC. RCC is the most common recipient tumor (71.7%) and the second is sarcoma (6.5%) [15] . The most common donor cancers are lung, prostate and thyroid [15] . In co-existing malignancies with RCC, Sella and Ro [15] report on 15% incidence of tumor to tumor metastasis. Three of these were female patients with asymptomatic renal cell carcinoma that contained metastasis from the breast, colon and lung cancer that was detected at autopsy [15] .
Two mechanisms have been postulated to explain the phenomenon of metastasis to RCC [13] Ulamec 8 8 1) Mechanical theory [15] is based on the fact that 25% of the minute volume flow goes through the kidney and RCC, which is highly vascular. Because of this RCC is receiving a large proportion of donor tumor emboli.
2) The "seed and soil" theory Breast carcinoma is known to coexist and metastasize more often to intracranial meningeoma [19] . In the literature there are only 4 cases of breast carcinoma metastasizing to RCC [6, 15, 17, 18] . Two cases are described in living patients with known metastatic breast cancer including metastasis to RCC [7, 18] . In the report by Sella and Ro, it was discovered at autopsy [15] . It can be expected that cases like this may be more often discovered in living patients because of the widespread use of ultrasonography and computer tomography in imaging of the kidneys as part of abdominal evaluation of other diseases [7] .
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To our knowledge, the case presented is the first case of breast carcinoma with neuroendocrine differentiation metastatic to RCC reported in the literature. In our case, RCC was found first and then other malignancy was suspected and actually diagnosed almost synchronously. Neuroendocrine breast carcinoma is quite uncommon, accounting for 2%-5% of breast carcinomas [16] . In the differential diagnosis, a primary neuroendocrine tumor of the kidney, especially carcinoma should be considered. Neuroendocrine carcinoma of the kidney accounts for much less than 1% of all epithelial renal malignant tumors [5] . Gross and microscopic features are similar to the same tumor type occurring at other, more typical locations. A concomitant urothelial carcinoma is common [5] . In summary, multiple synchronous primary malignances are rare but may be occasionally seen. One should be especially careful in patients with RCC where the incidence is even higher. A newly diagnosed renal tumor next to an existing cancer is challenging since a primary or a secondary renal neoplasm has to be considered in the differential diagnosis. 
